Immune profiling of COVID-19: preliminary findings and implications for the pandemic.

Journal for Immunotherapy of Cancer
Holden T Maecker

Abstract

SARS-CoV-2 infection can have widely diverse clinical outcomes, from asymptomatic infection to death, with many possible clinical symptoms and syndromes. It is thus essential to understand how the virus interacts with the host immune system to bring about these varied outcomes and to inform vaccine development. We now know that both antibody and T cell responses are induced in the majority of infected individuals, and that cross-reactive responses from other coronaviruses also exist in the uninfected population. Innate immune responses are a key focus of research and may influence the course of disease and the character of subsequent adaptive responses. Finally, baseline immune profiles and changes during early acute infection may be key to predicting the course of disease. Understanding all these aspects can help to create better immune monitoring tools for COVID-19, including tools for predicting disease severity or specific sequelae, perhaps even prior to infection.

References

Jun 22, 2017·Nature·Jacob GlanvilleMark M Davis
Aug 2, 2017·Nature Methods·Marlon StoeckiusPeter Smibert
Oct 23, 2018·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Leonard NetteyPratip K Chattopadhyay
Sep 11, 2019·Methods in Molecular Biology·Bita SahafSean C Bendall
Mar 7, 2020·Nature Reviews. Immunology·Mihai G NeteaEicke Latz
Apr 7, 2020·Journal of Medical Virology·Mushtaq HussainBasma Aziz
Apr 16, 2020·Journal of Medical Virology·Jieyun ZhuChunling Zhao
Apr 22, 2020·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Yong HuYancheng Xu
Apr 29, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Thirumalaisamy P Velavan, Christian G Meyer
May 3, 2020·Emerging Microbes & Infections·Baoqing SunLing Chen
May 13, 2020·Nature Reviews. Immunology·Luke A J O'Neill, Mihai G Netea
May 29, 2020·The Journal of Clinical Investigation·Alessio MazzoniLorenzo Cosmi
Jun 9, 2020·BioRxiv : the Preprint Server for Biology·Rafael R de AssisSaahir Khan
Jun 10, 2020·Nature Medicine·Aaron J WilkCatherine A Blish
Jun 18, 2020·Nature Reviews. Immunology·Anne H Rowley
Jul 1, 2020·JAMA Internal Medicine·Pratik SinhaCarolyn S Calfee
Jul 3, 2020·Frontiers in Immunology·Dina RagabRamy Salem
Jul 17, 2020·Science Immunology·Leticia Kuri-CervantesMichael R Betts
Jul 17, 2020·Reviews in Medical Virology·Seilesh KadambariAndrew J Pollard
Jul 25, 2020·JCI Insight·Jennifer G WilsonAngela J Rogers
Jul 28, 2020·Nature·Carolina LucasAkiko Iwasaki
Jul 29, 2020·Clinical and Experimental Medicine·Maria GavriatopoulouMeletios A Dimopoulos
Aug 4, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kai WangAi-Long Huang
Aug 14, 2020·Nature Immunology·Ji-Yuan ZhangFu-Sheng Wang
Aug 14, 2020·Immunity·Runhong ZhouZhiwei Chen
Aug 19, 2020·Nature Medicine·Adam G LaingAdrian C Hayday
Aug 19, 2020·Cell·Jonas Schulte-SchreppingUNKNOWN Deutsche COVID-19 OMICS Initiative (DeCOI)
Aug 21, 2020·Archives of Pathology & Laboratory Medicine·Youley TjendraCarolyn Cray
Aug 23, 2020·Science Immunology·Christopher MaucourantUNKNOWN Karolinska COVID-19 Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.